Clinical Trials Browser

Completed × darinaparsin × Clear all

Lymphoma, T-Cell, Peripheral

NCT01435863 2015-08-13

A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL)

Phase 1 Completed

17 enrolled

Lymphoid

Lymphoma, T-Cell, Peripheral

NCT01689220 2014-09-04

A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) in Korea

Phase 1 Completed

6 enrolled

Lymphoid

Lymphoma, T-Cell, Peripheral

NCT00509782 2012-08-01

Phase I Trial of ZIO-101 in Patients With Solid Tumors

Phase 1 Completed

47 enrolled

Other solid neoplasm

Solid Tumors

NCT00421213 2012-07-19

Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers

Phase 2 Completed

50 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Bone Marrow Neoplasms, Hematologic Neoplasms

NCT00591396 2012-07-19

A Phase I Trial of ZIO-101 in Solid Tumors

Phase 1 Completed

40 enrolled

Other solid neoplasm

Solid Tumors

NCT00592046 2012-07-19

A Phase I Trial of ZIO-101 in Hematologic Cancers

Phase 1 Completed

12 enrolled

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphoma, Multiple Myeloma, Myeloproliferative Disorders, Recurrence, Hematologic Neoplasms

NCT01139346 2012-07-19

Study of Oral Darinaparsin in Patients With Advanced Solid Tumors

Phase 1 Completed

12 enrolled

Sarcoma

Carcinoma, Neoplasm Metastasis, Sarcoma

Clinical Trials

A Phase 2 Study of SP-02L in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL)

A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) in Korea

Phase I Trial of ZIO-101 in Patients With Solid Tumors

Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers

A Phase I Trial of ZIO-101 in Solid Tumors

A Phase I Trial of ZIO-101 in Hematologic Cancers

Study of Oral Darinaparsin in Patients With Advanced Solid Tumors